Skip to main content

Vera Therapeutics, Inc.

VERA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001831828

In the last 90 days, Vera Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 219 institutions reported holding it in 13F filings for Q2 2026, worth $3.34B in total; no superinvestor holds it.

13F holders, Q3 2022

Institutional positions in Vera Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
55
+4 vs. Q2 2022
Shares held
21.5M
+1.14M (+5.6%) vs. Q2 2022
Total value
$459.0M
+$181.4M (+65.3%) vs. Q2 2022
New holders
7
25 more added
Sold out
3
9 more reduced

Compare with Q2 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting VERA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2022: 55 institutions
Q1 2021: 0 institutionsQ2 2021: 22 institutionsQ3 2021: 31 institutionsQ4 2021: 37 institutionsQ1 2022: 50 institutionsQ2 2022: 51 institutionsQ3 2022: 55 institutionsQ4 2022: 59 institutionsQ1 2023: 70 institutionsQ2 2023: 76 institutionsQ3 2023: 84 institutionsQ4 2023: 95 institutionsQ1 2024: 159 institutionsQ2 2024: 171 institutionsQ3 2024: 173 institutionsQ4 2024: 178 institutionsQ1 2025: 179 institutionsQ2 2025: 172 institutionsQ3 2025: 176 institutionsQ4 2025: 214 institutionsQ1 2026: 229 institutionsQ2 2026: 219 institutions
Value heldQ3 2022: $459.0M
Q1 2021: $0Q2 2021: $186.1MQ3 2021: $252.4MQ4 2021: $374.9MQ1 2022: $468.9MQ2 2022: $277.6MQ3 2022: $459.0MQ4 2022: $412.8MQ1 2023: $289.7MQ2 2023: $611.9MQ3 2023: $538.2MQ4 2023: $637.2MQ1 2024: $2.21BQ2 2024: $1.92BQ3 2024: $2.37BQ4 2024: $2.66BQ1 2025: $1.52BQ2 2025: $1.51BQ3 2025: $1.89BQ4 2025: $3.75BQ1 2026: $2.92BQ2 2026: $3.34B
Institutions holding VERA and their total value by quarter
QuarterHoldersValue
Q2 2026219$3.34B
Q1 2026229$2.92B
Q4 2025214$3.75B
Q3 2025176$1.89B
Q2 2025172$1.51B
Q1 2025179$1.52B
Q4 2024178$2.66B
Q3 2024173$2.37B
Q2 2024171$1.92B
Q1 2024159$2.21B
Q4 202395$637.2M
Q3 202384$538.2M
Q2 202376$611.9M
Q1 202370$289.7M
Q4 202259$412.8M
Q3 202255$459.0M
Q2 202251$277.6M
Q1 202250$468.9M
Q4 202137$374.9M
Q3 202131$252.4M
Q2 202122$186.1M
Q1 20210$0

Institutions, Q3 2022

Shares, value and share of portfolio for each institution holding Vera Therapeutics, Inc.; share changes are against Q2 2022.

Institutions holding VERA in Q3 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Wells Fargo & Company231$5.00K0.00%−112−32.7%Reduced
Royal Bank of Canada671$15.0K0.00%+93+16.1%Added
Ameritas Investment Partners, Inc.1,061$22.0K0.00%00.0%Unchanged
Metropolitan Life Insurance Co1,041$22.2K0.00%00.0%Unchanged
Citigroup Inc1,250$27.0K0.00%−9,980−88.9%Reduced
Tower Research Capital LLC (TRC)1,535$33.0K0.00%+105+7.3%Added
STRS Ohio1,600$34.0K0.00%00.0%Unchanged
Amalgamated Bank2,203$47.0K0.00%+46+2.1%Added
Cubist Systematic Strategies, LLC5,000$107.0K0.00%+5,000New
BNP Paribas Arbitrage, SA5,183$110.5K0.00%+5,183New
UBS Group AG5,298$113.0K0.00%+4,903+1,241.3%Added
Legal & General Group Plc5,386$114.0K0.00%+488+10.0%Added
Deutsche Bank AG6,256$133.0K0.00%−2,317−27.0%Reduced
American International Group, Inc.6,651$142.0K0.00%+163+2.5%Added
MetLife Investment Management8,881$189.3K0.00%00.0%Unchanged
Credit Suisse AG9,667$207.0K0.00%+63+0.7%Added
Cambridge Trust Co9,887$211.0K0.01%00.0%Unchanged
Barclays PLC10,025$214.0K0.00%+9,329+1,340.4%Added
New York State Common Retirement Fund11,016$235.0K0.00%+34+0.3%Added
Alps Advisors Inc14,744$314.0K0.00%−1,316−8.2%Reduced
State of Wisconsin Investment Board15,051$321.0K0.00%+15,051New
Carnegie Mellon University16,060$342.0K0.19%00.0%Unchanged
Rhumbline Advisers17,600$375.0K0.00%+1,328+8.2%Added
Raymond James Financial Services Advisors, Inc.17,828$380.0K0.00%00.0%Unchanged
California State Teachers Retirement System18,335$391.0K0.00%−219−1.2%Reduced
Gyon Technologies Capital Management, LP20,431$435.0K0.14%+20,431New
Ensign Peak Advisors, Inc21,116$450.0K0.00%+7,839+59.0%Added
Morgan Stanley22,960$489.0K0.00%+19,495+562.6%Added
Bank of America Corp34,397$733.0K0.00%+12,943+60.3%Added
Swiss National Bank34,700$739.0K0.00%00.0%Unchanged
Charles Schwab Investment Management Inc37,890$808.0K0.00%+3,199+9.2%Added
Bank of New York Mellon Corp69,498$1.48M0.00%−5,586−7.4%Reduced
JPMorgan Chase & Co75,330$1.60M0.00%−23,606−23.9%Reduced
Nuveen Asset Management, LLC89,666$1.91M0.00%+15,344+20.6%Added
Northern Trust Corp114,870$2.45M0.00%+2,400+2.1%Added
Point72 Asset Management, L.P.121,000$2.58M0.01%+121,000New
Eversept Partners, LP156,129$3.33M0.39%+156,129New
Woodline Partners LP169,277$3.61M0.05%+169,277New
Geode Capital Management, LLC239,800$5.11M0.00%+35,212+17.2%Added
State Street Corp249,783$5.32M0.00%+27,528+12.4%Added
International Biotechnology Trust PLC281,257$5.99M1.92%+277,432+7,253.1%Added
Alphabet Inc.301,580$6.43M0.33%00.0%Unchanged
Baker Bros. Advisors LP333,333$7.10M0.05%00.0%Unchanged
Millennium Management LLC396,928$8.46M0.01%+120,685+43.7%Added
Polar Asset Management Partners Inc.523,400$11.2M0.15%+229,100+77.8%Added
Octagon Capital Advisors LP533,264$11.4M1.96%−41,736−7.3%Reduced
Vivo Capital, LLC666,666$14.2M1.57%00.0%Unchanged
Vanguard Group Inc758,832$16.2M0.00%+81,895+12.1%Added
BlackRock Inc.790,795$16.9M0.00%+73,761+10.3%Added
Kynam Capital Management, LP1,536,181$32.7M6.92%+13,469+0.9%Added
Ra Capital Management, L.P.1,578,820$33.6M0.72%00.0%Unchanged
Citadel Advisors LLC1,991,473$42.4M0.05%−131,378−6.2%Reduced
Abingworth LLP2,960,231$63.1M21.57%00.0%Unchanged
Sofinnova Investments, Inc.3,181,442$67.8M4.31%00.0%Unchanged
FMR LLC4,056,341$86.4M0.01%+40,990+1.0%Added
Bank of Montreal0$00.00%−96,849−100.0%Sold out
Dynamic Technology Lab Private Ltd0$00.00%−11,939−100.0%Sold out
State of Wyoming0$00.00%−28−100.0%Sold out